All COVID-19
Give Now
Words of Encouragement
Healthcare Heroes
Dev Homepage
ICU Special Campaign
Research
Recent Stories
The first round of voting for STAT Madness began today. Included in the first round is the BIDMC team, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), who in collaboration with Johnson & Johnson developed and conducted preclinical testing of a single-dose COVID-19 vaccine, which is one of three COVID-19 vaccines cleared for emergency use in the U.S.
FDA issues emergency use authorization for Johnson & Johnson vaccine
The Johnson & Johnson vaccine, which was developed in collaboration with BIDMC, was authorized Saturday for use in the U.S. Experts in gene-based technology, including Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) led the team that developed the vaccine in a collaboration between Johnson & Johnson and BIDMC, and shared what its approval will mean for the state of Massachusetts’s vaccination efforts.
According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).
